[
  "Jean-Paul and Martine Clozel cofounded Swiss biotech firm Actelion in 1997 with three other colleagues. ",
  "The husband-and-wife team sold the company to Johnson & Johnson for $30 billion in 2017. ",
  "Actelion makes drugs for orphan diseases, which affect fewer than 200,000 people\r\nand typically receive little research funding. \r\n",
  "Following the Johnson & Johnson acquisition, the couple spun out publicly-traded Idorsia, which they now run together. ",
  "Idorsia is specializing in the discovery and development of small molecules to eventually develop drugs to treat insomnia, lupus and other diseases. "
]